| scholarly article | Q13442814 |
| P50 | author | Scott C. Weaver | Q22583669 |
| Chao Shan | Q56886476 | ||
| Pei-Yong Shi | Q59435668 | ||
| Tian Wang | Q61159575 | ||
| Jing Zou | Q64160223 | ||
| Antonio E Muruato | Q66738971 | ||
| Christopher M Roundy | Q66739195 | ||
| Huanle Luo | Q66753269 | ||
| Daniele B A Medeiros | Q92950632 | ||
| Shannan L Rossi | Q46145125 | ||
| Xuping Xie | Q54118103 | ||
| P2093 | author name string | Maki Wakamiya | |
| Camila R Fontes-Garfias | |||
| Elizabeth Mays | |||
| P2860 | cites work | Zika virus. I. Isolations and serological specificity | Q22240545 |
| Zika Virus in the Americas — Yet Another Arbovirus Threat | Q22248116 | ||
| Biology of Zika Virus Infection in Human Skin Cells | Q22330706 | ||
| Characterization of a Novel Murine Model to Study Zika Virus | Q23667364 | ||
| The 3.8 Å resolution cryo-EM structure of Zika virus | Q23680595 | ||
| Zika Virus: Diagnosis, Therapeutics, and Vaccine | Q24067899 | ||
| An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors | Q24261403 | ||
| Zika virus: History, emergence, biology, and prospects for control | Q24261421 | ||
| Defining the syndrome associated with congenital Zika virus infection | Q24570087 | ||
| Glycosylation and antigenic variation among Kunjin virus isolates | Q24727672 | ||
| Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses | Q24727674 | ||
| Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains | Q27469847 | ||
| Essential Role of Dengue Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral Propagation | Q27480927 | ||
| Interferon Regulatory Factor IRF-7 Induces the Antiviral Alpha Interferon Response and Protects against Lethal West Nile Virus Infection | Q27486785 | ||
| West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors | Q27489602 | ||
| Glycosylation of the West Nile Virus Envelope Protein Increases In Vivo and In Vitro Viral Multiplication in Birds | Q27491308 | ||
| A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine | Q28729772 | ||
| Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis | Q28735954 | ||
| A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models | Q29352360 | ||
| Variation in Aedes aegypti Mosquito Competence for Zika Virus Transmission | Q29365410 | ||
| Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis | Q29615108 | ||
| Composition and three-dimensional architecture of the dengue virus replication and assembly sites | Q29615112 | ||
| Structure of West Nile Virus | Q29618173 | ||
| Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network | Q30402859 | ||
| Both E protein glycans adversely affect dengue virus infectivity but are beneficial for virion release | Q33826834 | ||
| A C-Type Lectin Collaborates with a CD45 Phosphatase Homolog to Facilitate West Nile Virus Infection of Mosquitoes | Q34195900 | ||
| Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention | Q35097106 | ||
| Genome sequence and attenuating mutations in West Nile virus isolate from Mexico | Q35881143 | ||
| Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease | Q38157833 | ||
| Flavivirus structural heterogeneity: implications for cell entry | Q38158126 | ||
| Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology | Q38174301 | ||
| Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals | Q38327330 | ||
| Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes | Q40125127 | ||
| Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness | Q40311131 | ||
| Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. | Q40486490 | ||
| Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4. | Q40512368 | ||
| Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains | Q40734353 | ||
| Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus | Q42988971 | ||
| Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus | Q43035315 | ||
| P433 | issue | 5 | |
| P921 | main subject | Zika virus | Q202864 |
| glycosylation | Q898365 | ||
| P1104 | number of pages | 11 | |
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P304 | page(s) | 1180-1190 | |
| P577 | publication date | 2017-10-01 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | Functional Analysis of Glycosylation of Zika Virus Envelope Protein | |
| P478 | volume | 21 |
| Q52572353 | 14-3-3β/α-A interacts with glycoprotein of spring viremia of carp virus and positively affects viral entry. |
| Q93017534 | A Chimeric Zika Virus between Viral Strains MR766 and BeH819015 Highlights a Role for E-glycan Loop in Antibody-mediated Virus Neutralization |
| Q59358841 | A Single Mutation at Position 156 in the Envelope Protein of Tembusu Virus Is Responsible for Virus Tissue Tropism and Transmissibility in Ducks |
| Q57283094 | A Single-Dose Live-Attenuated Zika Virus Vaccine with Controlled Infection Rounds that Protects against Vertical Transmission |
| Q98196536 | A Zika virus envelope mutation preceding the 2015 epidemic enhances virulence and fitness for transmission |
| Q110771242 | A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission |
| Q91896300 | A method for rapid and high-yield production of the tick-borne encephalitis virus E and DIII recombinant proteins in E. coli with preservation of the antigenic properties |
| Q110770919 | A single nonsynonymous mutation on ZIKV E protein-coding sequences leads to markedly increased neurovirulence in vivo |
| Q110457457 | AXL, an Important Host Factor for DENV and ZIKV Replication |
| Q90230085 | An Attenuated Zika Virus Encoding Non-Glycosylated Envelope (E) and Non-Structural Protein 1 (NS1) Confers Complete Protection against Lethal Challenge in a Mouse Model |
| Q63248516 | Anti-Zika Activity of a Library of Synthetic Carbohydrate Receptors |
| Q55026039 | Autoimmune Neurological Conditions Associated With Zika Virus Infection. |
| Q90131024 | Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses |
| Q55277816 | Biochemistry and Molecular Biology of Flaviviruses. |
| Q99202176 | C-Type Lectins Link Immunological and Reproductive Processes in Aedes aegypti |
| Q99574108 | Castanospermine reduces Zika virus infection-associated seizure by inhibiting both the viral load and inflammation in mouse models |
| Q57008172 | Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine |
| Q90282580 | Comparative Analysis of African and Asian Lineage-Derived Zika Virus Strains Reveals Differences in Activation of and Sensitivity to Antiviral Innate Immunity |
| Q84957757 | CpG-Recoding in Zika Virus Genome Causes Host-Age-Dependent Attenuation of Infection With Protection Against Lethal Heterologous Challenge in Mice |
| Q62485179 | Determinants of Zika virus host tropism uncovered by deep mutational scanning |
| Q56347896 | Different footprints of the Zika and dengue surface proteins on viral membranes |
| Q91862903 | Discovery of Novel Crustacean and Cephalopod Flaviviruses: Insights into the Evolution and Circulation of Flaviviruses between Marine Invertebrate and Vertebrate Hosts |
| Q58784010 | Early Events in Japanese Encephalitis Virus Infection: Viral Entry |
| Q63248501 | Envelope protein glycosylation mediates Zika virus pathogenesis |
| Q97535084 | Envelope protein ubiquitination drives entry and pathogenesis of Zika virus |
| Q64359271 | Exploitation of glycosylation in enveloped virus pathobiology |
| Q90244931 | Flavivirus envelope protein glycosylation: impacts on viral infection and pathogenesis |
| Q115233761 | Flavivirus maturation leads to the formation of an occupied lipid pocket in the surface glycoproteins |
| Q91676273 | Generation of Zika virus-specific T cells from seropositive and virus-naïve donors for potential use as an autologous or "off-the-shelf" immunotherapeutic |
| Q93165825 | Genetic stability of live-attenuated Zika vaccine candidates |
| Q94592766 | Glucose-Regulated Protein 78 Interacts with Zika Virus Envelope Protein and Contributes to a Productive Infection |
| Q93207540 | Glycosylation as a tool for rational vaccine design |
| Q95630244 | Glycosylation of Zika Virus Is Important in Host-Virus Interaction and Pathogenesis |
| Q90877230 | Glycosylation of Zika Virus is Important in Host-Virus Interaction and Pathogenic Potential |
| Q110771212 | Identification of a Zika NS2B epitope as a biomarker for severe clinical phenotypes |
| Q98243957 | Iminosugars: a host-targeted approach to combat Flaviviridae infections |
| Q101472255 | Immune Reactivity of a 20-mer Peptide Representing the Zika E Glycan Loop Involves the Antigenic Determinants E-152/156/158 |
| Q102066490 | Interference of the Zika Virus E-Protein With the Membrane Attack Complex of the Complement System |
| Q90796645 | Investigation of the immunogenicity of Zika glycan loop |
| Q56361211 | Micro-droplet Digital Polymerase Chain Reaction and Real-Time Quantitative Polymerase Chain Reaction Technologies Provide Highly Sensitive and Accurate Detection of Zika Virus |
| Q92616571 | Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti |
| Q59245631 | Multimodal assessments of Zika virus immune pathophysiological responses in marmosets |
| Q92288776 | Mutational landscape of Zika virus strains worldwide and its structural impact on proteins |
| Q98723532 | N-glycosylation in the Pre-Membrane Protein Is Essential for the Zika Virus Life Cycle |
| Q49791115 | N-glycosylation of Viral E Protein Is the Determinant for Vector Midgut Invasion by Flaviviruses |
| Q66679143 | N-linked glycosylation of the West Nile virus envelope protein is not a requisite for avian virulence or vector competence |
| Q56341811 | Potential targets for therapeutic intervention and structure based vaccine design against Zika virus |
| Q54221789 | Probing Molecular Insights into Zika Virus⁻Host Interactions. |
| Q56348817 | Probing Zika virus neutralization determinants with glycoprotein mutants bearing linear epitope insertions |
| Q110771052 | Rearrangement of Actin Cytoskeleton by Zika Virus Infection Facilitates Blood-Testis Barrier Hyperpermeability |
| Q59245656 | Recent Advances in Zika Virus Vaccines |
| Q110771090 | Recent progresses and remaining challenges for the detection of Zika virus |
| Q96616005 | Reserve genetic approaches for the development of Zika vaccines and therapeutics |
| Q62485314 | Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity |
| Q110770889 | Site-specific N-glycosylation analysis of animal cell culture-derived Zika virus proteins |
| Q61053963 | Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope |
| Q101126223 | Synthetic Carbohydrate Chemistry and Translational Medicine |
| Q112076561 | The Ablation of Envelope Protein Glycosylation Enhances the Neurovirulence of ZIKV and Cell Apoptosis in Newborn Mice |
| Q91299607 | The Envelope Residues E152/156/158 of Zika Virus Influence the Early Stages of Virus Infection in Human Cells |
| Q61795461 | The Roles of prM-E Proteins in Historical and Epidemic Zika Virus-mediated Infection and Neurocytotoxicity |
| Q104486313 | The Substantial Attenuation of Virulence of Tembusu Virus Strain PS Is Determined by an Arg at Residue 304 of the Envelope Protein |
| Q53073370 | The recognition of glycans by protein receptors. Insights from NMR spectroscopy. |
| Q112076758 | USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination |
| Q61053683 | Uncovering Flavivirus Host Dependency Factors through a Genome-Wide Gain-of-Function Screen |
| Q92340084 | ZAP, a CCCH-Type Zinc Finger Protein, Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication and Interacts with Viral Nsp9 |
| Q61053671 | ZIKA virus entry mechanisms in human cells |
| Q100695869 | ZIKV viral proteins and their roles in virus-host interactions |
| Q56339878 | Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models |
| Q89685640 | Zika Virus Mucosal Infection Provides Protective Immunity |
| Q94959432 | Zika structural genes determine the virulence of African and Asian lineages |
| Q110770886 | Zika virus baculovirus-expressed envelope protein elicited humoral and cellular immunity in immunocompetent mice |
| Q92076770 | Zika virus: Molecular responses and tissue tropism in the mammalian host |
| Q63248445 | Zika viruses of African and Asian lineages cause fetal harm in a mouse model of vertical transmission |
| Q92144311 | [The Recent Epidemic Spread of Zika Virus Disease] |
Search more.